LFST: financial statements from SEC — TradeAlmanac

LFST

LifeStance Health Group, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Dec 2025	31 Dec 2024
Revenue	1.42B	1.25B
Selling, general and administrative	382M	363M
Operating expenses	1.40B	1.28B
Operating income	24M	−32M
Pre-tax income	12M	−58M
Income tax	3M	−170,000
Net income	10M	−57M
Earnings per share	0.03	−0.15
Earnings per share, diluted	0.02	−0.15
Weighted average shares	386M	379M
Weighted average shares, diluted	391M	379M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	195M	249M	204M	189M	134M	155M	103M	87M
Receivables	123M	96M	121M

Cash flow

Metric	31 Dec 2025	31 Dec 2024
Operating cash flow	146M	107M
Depreciation and amortisation	55M	71M
Share-based compensation	75M	76M
Capital expenditure	36M	22M
Investing cash flow	−36M	−22M
Financing cash flow	−16M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator